Iron in Chronic Kidney Disease and End-Stage Kidney Disease-Current Trends and Future Direction

Thomas McDonnell1,2, Philip A Kalra1,2

  • 1Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.

Insights

Anemia is a common complication in chronic kidney disease (CKD). Iron deficiency, both absolute and functional, significantly impacts CKD anemia, necessitating a review of intravenous iron therapies.

Area of Science:

  • Nephrology
  • Hematology

Background:

  • Anemia is a frequent complication in chronic kidney disease (CKD), impacting both non-dialysis-dependent (NDD) and dialysis-dependent (DD) patients.
  • Erythropoietin (EPO) deficiency is a primary cause, but iron deficiency (ID) is also crucial.
  • ID in CKD presents as absolute (blood loss) or functional (inflammation, elevated hepcidin), hindering erythropoiesis and oral iron absorption.

Purpose of the Study:

  • To review current intravenous (IV) iron formulations for CKD anemia.
  • To discuss diagnostic criteria and treatment thresholds for ID in NDD and DD CKD patients.
  • To explore future therapeutic strategies for managing iron deficiency in CKD.

Main Methods:

  • Literature review of available intravenous iron formulations.
  • Analysis of diagnostic definitions and treatment thresholds for iron deficiency in CKD.
  • Exploration of emerging therapeutic directions for iron management in CKD.

Main Results:

  • Intravenous iron formulations offer an alternative when oral iron is ineffective, particularly in advanced CKD.
  • Clear diagnostic definitions and treatment thresholds are essential for effective ID management.
  • Functional iron deficiency, driven by inflammation and hepcidin, poses unique challenges.

Conclusions:

  • Intravenous iron is vital for managing anemia in CKD patients with iron deficiency.
  • Optimizing diagnosis and treatment thresholds for ID is critical for improving patient outcomes.
  • Further research into novel therapeutic approaches is needed to address the complexities of iron metabolism in CKD.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
249
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
68.6K
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.0K